Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
AI Sentiment
Highly Positive
8/10
as of 12-03-2025 4:00pm EST
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 24.3M | IPO Year: | 2018 |
| Target Price: | $6.33 | AVG Volume (30 days): | 303.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.45 - $22.80 | Next Earning Date: | 11-13-2025 |
| Revenue: | $28,720,000 | Revenue Growth: | -13.84% |
| Revenue Growth (this year): | -6.75% | Revenue Growth (next year): | 24.54% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
BNGO Breaking Stock News: Dive into BNGO Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
See how BNGO stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "BNGO Bionano Genomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.